EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dipropyleneglycol Dimethylether, New Green Solvent for Solid-Phase Peptide Synthesis: Further Challenges to Improve Sustainability in the Development of Therapeutic Peptides

Giovanni Vivenzio, Maria Carmina Scala, Pasquale Marino iD, Michele Manfra iD, Pietro Campiglia iD, Marina Sala iD

Pharmaceutics · 20.06.2023 · 15 (6) · 1773

DOI: 10.3390/pharmaceutics15061773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 20.06.2023. Verfasst von Giovanni Vivenzio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, Fisciano, 84084 Salerno, Italy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “PROGEMA” (PROcessi Green per l’Estrazione di principi attivi e la depurazione di MAtrici di scarto e non).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, peptides have gained more success as therapeutic compounds. Nowadays, the preferred method to obtain peptides is solid-phase peptide synthesis (SPPS), which does not respect the principles of green chemistry due to the large number of toxic reagents and solvents used. The aim of this work was to research and study an environmentally sustainable solvent able to replace dimethylformamide (DMF) in fluorenyl methoxycarbonyl (Fmoc) solid-phase peptide synthesis. Herein, we report the use of dipropyleneglycol dimethylether (DMM), a well-known green solvent with low human toxicity following oral, inhalant, and dermal exposure and that is easily biodegradable. Some tests were needed to evaluate its applicability to all the steps of SPPS, such as amino acid solubility, resin swelling, deprotection kinetics, and coupling tests. Once the best green protocol was established, it was applied to the synthesis of different length peptides to study some of the fundamental parameters of green chemistry, such as PMI (process mass intensity) and the recycling of solvent. It was revealed that DMM is a valuable alternative to DMF in all steps of solid-phase peptide synthesis.

Schlagwörter

Stichwörter der Autor:innen

dipropyleneglycol dimethylethergreen chemistrypeptidesrecyclingsolid-phase peptide synthesis

Autor:innen und Institutionen

  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, Fisciano, 84084 Salerno, Italy.
  • Department of Sciences, University of Basilicata, Via dell'Ateneo Lucano 10, 85100 Potenza, Italy.

ORCID-Profile: Pasquale Marino, Michele Manfra, Pietro Campiglia, Marina Sala

Förderung

  • “PROGEMA” (PROcessi Green per l’Estrazione di principi attivi e la depurazione di MAtrici di scarto e non)

Zitieren

APA

Vivenzio, G., Scala, M. C., Marino, P., Manfra, M., Campiglia, P., & Sala, M. (2023). Dipropyleneglycol Dimethylether, New Green Solvent for Solid-Phase Peptide Synthesis: Further Challenges to Improve Sustainability in the Development of Therapeutic Peptides. Pharmaceutics, 15(6), 1773. https://doi.org/10.3390/pharmaceutics15061773

Vancouver

Vivenzio G, Scala MC, Marino P, Manfra M, Campiglia P, Sala M. Dipropyleneglycol Dimethylether, New Green Solvent for Solid-Phase Peptide Synthesis: Further Challenges to Improve Sustainability in the Development of Therapeutic Peptides. Pharmaceutics. 2023;15(6):1773. doi:10.3390/pharmaceutics15061773

BibTeX
@article{Vivenzio2023,
  author = {Vivenzio, Giovanni and Scala, Maria Carmina and Marino, Pasquale and Manfra, Michele and Campiglia, Pietro and Sala, Marina},
  title = {Dipropyleneglycol Dimethylether, New Green Solvent for Solid-Phase Peptide Synthesis: Further Challenges to Improve Sustainability in the Development of Therapeutic Peptides},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1773},
  doi = {10.3390/pharmaceutics15061773}
}
Kostenlos starten →